Dare Bioscience, Inc. 8-K

What Happened

• Daré Bioscience, Inc. (DARE) filed a Form 8-K on March 2, 2026 (Item 7.01) to disclose that it made an updated corporate presentation available in the "Investors" section of its website (https://ir.darebioscience.com).
• A copy of the presentation dated March 2, 2026 is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference into the filing.

Key Details

• Filing date: March 2, 2026.
• Disclosure type: Regulation FD disclosure (Item 7.01 on Form 8-K).
• Presentation posted to: Daré’s investor website at https://ir.darebioscience.com.
• Exhibit filed: Exhibit 99.1 — corporate presentation dated March 2, 2026.

Why It Matters

• The company has publicly posted its latest investor presentation, so shareholders and prospective investors can review Daré’s most recent corporate overview, strategy, pipeline highlights, and any disclosed timelines or milestones directly from the company.
• Posting under Regulation FD signals the company is broadly disseminating information to ensure fair access to investors; reviewing the presentation is recommended for anyone tracking DARE’s development progress or upcoming catalysts.